Arteriovenous Fistula Global Clinical Trials Review, H1, 2015

Arteriovenous Fistula Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2649CTIDB
  • |
  • Pages: 61
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Arteriovenous Fistula Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Arteriovenous Fistula Global Clinical Trials Review, H1, 2015" provides data on the Arteriovenous Fistula clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arteriovenous Fistula. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arteriovenous Fistula. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Arteriovenous Fistula 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Clinical Trials by End Point Status 21

Unaccomplished Trials of Arteriovenous Fistula 22

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Arteriovenous Fistula Therapeutics Clinical Trials 27

Prominent Drugs 28

Latest Clinical Trials News on Arteriovenous Fistula 29

Apr 13, 2015: Proteon Therapeutics to Present at Two International Vascular Access Conferences 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Shire Plc 30

Clinical Trial Overview of Shire Plc 30

Proteon Therapeutics, Inc. 31

Clinical Trial Overview of Proteon Therapeutics, Inc. 31

CYATHUS EXQUIRERE Pharmaforschungs GmbH 32

Clinical Trial Overview of CYATHUS EXQUIRERE Pharmaforschungs GmbH 32

Celladon Corporation 33

Clinical Trial Overview of Celladon Corporation 33

Clinical Trial Overview of Top Institutes / Government 34

California Institute of Renal Research 34

Clinical Trial Overview of California Institute of Renal Research 34

Capital Medical University 35

Clinical Trial Overview of Capital Medical University 35

City Hospitals Sunderland NHS Foundation Trust 36

Clinical Trial Overview of City Hospitals Sunderland NHS Foundation Trust 36

Department of Health, UK 37

Clinical Trial Overview of Department of Health, UK 37

Duke University 38

Clinical Trial Overview of Duke University 38

Emory University 39

Clinical Trial Overview of Emory University 39

Englewood Hospital and Medical Center 40

Clinical Trial Overview of Englewood Hospital and Medical Center 40

Japan Interventional Radiology in Oncology Study Group 41

Clinical Trial Overview of Japan Interventional Radiology in Oncology Study Group 41

National Cheng-Kung University Hospital 42

Clinical Trial Overview of National Cheng-Kung University Hospital 42

NHS Greater Glasgow and Clyde 43

Clinical Trial Overview of NHS Greater Glasgow and Clyde 43

Five Key Clinical Profiles 44

Appendix 59

Abbreviations 59

Definitions 59

Research Methodology 60

Secondary Research 60

About GlobalData 61

Contact Us 61

Disclaimer 61

Source 61

List of Figures

Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14

Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17

Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18

Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19

Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24

Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28

GlobalData Methodology 60

List of Tables

Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Region, 2015* 7

Arteriovenous Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Arteriovenous Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Arteriovenous Fistula Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Arteriovenous Fistula Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Arteriovenous Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 14

Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Arteriovenous Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Arteriovenous Fistula to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 17

Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Phase, 2015* 18

Arteriovenous Fistula Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19

Arteriovenous Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Arteriovenous Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Arteriovenous Fistula Therapeutics, Global, Withdrawn Clinical Trials, 2015* 22

Arteriovenous Fistula Therapeutics, Global, Terminated Clinical Trials, 2015* 23

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24

Arteriovenous Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27

Arteriovenous Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 30

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Proteon Therapeutics, Inc., 2015* 31

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by CYATHUS EXQUIRERE PharmaforschungsGmbH, 2015* 32

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Celladon Corporation, 2015* 33

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by California Institute of Renal Research, 2015* 34

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015* 35

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by City Hospitals Sunderland NHS Foundation Trust, 2015* 36

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 37

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 38

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 39

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Englewood Hospital and Medical Center, 2015* 40

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Interventional Radiology in Oncology Study Group, 2015* 41

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cheng-Kung University Hospital, 2015* 42

Arteriovenous Fistula Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2015* 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Arteriovenous Fistula Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Arteriovenous Fistula, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 162625
Site License
USD 5000 INR 325250
Corporate User License
USD 7500 INR 487875

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com